MiMedx Group Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +6.3% | -2.4% | +2.9% | -3.6% | +10.5% | -5.1% | +11.8% | +15.3% | +3.8% | -50.0% | +9.1% | – | |
| – | -6.4% | -4.8% | +14.2% | +1.8% | +10.4% | -2.1% | +12.8% | +0.2% | +1.8% | -8.9% | +15.0% | – | |
| – | +9.1% | -2.0% | +0.9% | -4.7% | +10.6% | -5.7% | +11.6% | +18.9% | +4.2% | -58.0% | +6.6% | – | |
| – | -20.9% | +16.8% | +6.0% | -3.1% | +22.4% | -6.8% | -0.8% | +12.1% | +28.6% | -13.1% | -32.9% | – | |
| – | +3.4% | +1.4% | +0.5% | -3.4% | +14.1% | -1.8% | -72.8% | -6.2% | +378.2% | -87.2% | +43.4% | – | |
| – | +3.1% | +1.8% | -16.4% | +17.7% | +12.8% | -2.4% | +6.6% | +7.8% | +6.9% | -25.9% | +9.0% | – | |
| – | +39.2% | -14.8% | +77.7% | -52.4% | -1.0% | -25.4% | +49.9% | +79.4% | -5.0% | -176.1% | – | – | |
| – | -5.2% | +6.1% | -99.8% | +9,166.7% | +809.7% | -81.1% | -0.6% | +65.3% | -48.4% | -0.7% | – | – | |
| – | +47.5% | -18.0% | +103.5% | -50.8% | -1.5% | -23.4% | +51.0% | +75.7% | -4.6% | -170.3% | – | – | |
| – | -6,424.0% | – | +138.3% | -36.7% | +7.6% | -58.3% | +113.3% | +80.0% | +8.3% | -167.7% | – | – | |
| – | +526.6% | -82.7% | +90.3% | -54.1% | -8.1% | -5.6% | +37.0% | +74.1% | -9.3% | -171.5% | – | – | |
| – | +36.4% | -14.0% | +73.6% | -48.2% | +12.1% | -12.9% | +35.0% | +74.0% | -12.1% | -154.0% | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.